Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1983;6(2):57-63.

[Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina]

[Article in Russian]
  • PMID: 6139118
Comparative Study

[Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina]

[Article in Russian]
A Iu Romakov et al. Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR. 1983.

Abstract

In 32 patients with angina of effort, the antianginal effects and action duration of propranolol, atenolol, labetalol and nadolol were compared during the exercise test after a single dose of the drug. Atenolol and nadolol have been ascertained to be effective long acting antianginal drugs. Except the antianginal effect duration, the above mentioned beta-blockers have not been found to be superior to propranolol, including to atenolol, to its effect on the total peripheral vascular resistance. Labetalol provided a sufficient antianginal effect in a number of patients, including those in whom propranolol was not effective enough. It have been found that high incidence of side effects makes it inexpedient to use high doses of labetalol (more than 200 mg) in patients with angina pectoris who have normal blood pressure.

PubMed Disclaimer

Similar articles

LinkOut - more resources